Harvard University Advanced Leadership Initiative

GCOM Announces Addition of Al Zollar to Board of Directors

Retrieved on: 
Thursday, September 9, 2021

COLUMBIA, Md., Sept. 9, 2021 /PRNewswire-PRWeb/ -- GCOM , the leader in outcome-driven technology solutions for state and local government, today announced the addition of Al Zollar to its board of directors, effective June 1, 2021.

Key Points: 
  • COLUMBIA, Md., Sept. 9, 2021 /PRNewswire-PRWeb/ -- GCOM , the leader in outcome-driven technology solutions for state and local government, today announced the addition of Al Zollar to its board of directors, effective June 1, 2021.
  • We've asked Al to join the board to advise the management team on expanding our portfolio of software assets.
  • "With a technology icon such as Al on our board, GCOM strengthens our position as a leader in enabling outcome-driven government," said Donna Morea, chairman of GCOM's board of directors.
  • GCOM's board of directors serves to advance the company's mission of helping government create healthier, safer, and more prosperous communities.

Avisa Diagnostics Appoints Dr. Richard Murray as Chief Medical Officer

Retrieved on: 
Wednesday, September 1, 2021
Industry, Company, ABT, Harvard University Advanced Leadership Initiative, University, Twitter, CSE, Harvard University, GLOBE, Tuberculosis, Merck, CMO, Disease, Merck & Co., Asthma, Hospital, Clark University, Community-acquired pneumonia, Safety, Ventilator-associated pneumonia, Patient, LinkedIn, Investigational device exemption, Howard University, Technology, Cystic fibrosis, Hospital of the University of Pennsylvania, Pharmaceutical industry

SANTA FE, N.M. and MALVERN, Pa., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT) (Avisa), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of virulent bacterial lung infections, is pleased to announce that the Company has hired Richard K. Murray, M.D., to the newly created position of Chief Medical Officer (CMO).

Key Points: 
  • SANTA FE, N.M. and MALVERN, Pa., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT) (Avisa), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of virulent bacterial lung infections, is pleased to announce that the Company has hired Richard K. Murray, M.D., to the newly created position of Chief Medical Officer (CMO).
  • He has managed all areas of medical affairs, including outcomes research, medical information, professional and academic affairs, field-based medical physicians, and investigator-initiated trials globally.
  • David S. Joseph, President and Chief Executive Officer of Avisa, said: We are thrilled to have Richard join our team.
  • Dr. Richard K. Murray, Chief Medical Officer of Avisa, added: I am excited to join the Avisa team at this critical stage in the companys development.